×

COPYRIGHT(C) 2022 AEVISBIO, INC. ALL RIGHTS RESERVED.

 

  • NEWS
  • Press Release

Press Release

Publication Notice

2021-07-31

Researches on immunomodulatory imides drug development under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the peer-reviewed publication, Int J Mol Sci. (July 31, 2021).

 

The publication, titled, “3,6'-Dithiopomalidomide Ameliorates Hippocampal Neurodegeneration, Microgliosis and Astrogliosis and Improves Cognitive Behaviors in Rats with a Moderate Traumatic Brain Injury” may be found here (10.3390/ijms22158276 ).